The Prognostic Value of Serum Biomarkers in Ewing's Sarcoma

The Prognostic Value of Serum Biomarkers in Ewing's Sarcoma

Extraction of laboratory data from blood tests prior to surgical and chemotherapy and other histological, clinical and instrumental data related to the patient's history from the digitized medical Digitized medical records and analysis of the same. The medical records of 1000 patients from January 1, 2000, until December 31, 2020

Inclusion Criteria:

• Patients with Ewing's Sarcoma and osteosarcoma with established diagnosis;
• Patients with age ≥ 2 years;
• Minimum follow-up duration of 2 years;
• Medical records, complete blood work and instrumental examinations; Regular follow-up.

Exclusion Criteria:

• Patients with Ewing's sarcoma or osteosarcoma who have received medical treatment (surgery radiotherapy or chemotherapy) in other institutions prior to admission to the Rizzoli Orthopaedic Institute.